-+ 0.00%
-+ 0.00%
-+ 0.00%

Kuros Biosciences Lifts FY26 Group Sales Growth Guidance

MT Newswires·10/15/2026 01:30:52
Listen to the news
01:30 AM EDT, 10/15/2026 (MT Newswires) -- Kuros Biosciences (KURN.SW) raised its group sales growth guidance for full-year 2026, according to a Thursday filing. The bone healing technologies company now expects group sales to rise 36% to 40% annually, compared with the August forecast of at least a 35% jump. For the nine months ended Sept. 30, the company reported total medical device sales of $141.8 million, compared with $101.1 million a year ago.